Organ Regeneration is a complex biological process where damaged or lost tissues in an organ are restored to their original structure and function. Unlike simple tissue repair, regeneration involves the restoration of specific cell types and tissue architecture. Many organisms, particularly amphibians and certain invertebrates, exhibit remarkable abilities for organ regeneration, such as limb regeneration in salamanders or heart regeneration in zebrafish. The process of organ regeneration typically involves a sequence of events, including inflammation, cellular dedifferentiation, proliferation, and differentiation. Inflammation signals the immune system to remove damaged cells, while dedifferentiation allows mature cells to revert to a more primitive state capable of proliferation. Proliferation involves the rapid division of cells, and subsequent differentiation directs the formation of specific cell types required for functional restoration. Mammals, including humans, exhibit limited organ regeneration compared to some other species. Nevertheless, certain organs possess regenerative capacities to varying extents, such as the liver's ability to regenerate after partial removal. Stem cells, which have the potential to differentiate into various cell types, play a crucial role in the regeneration process. Research in regenerative medicine explores ways to enhance and stimulate these intrinsic regenerative abilities. Scientists investigate various factors influencing organ regeneration, including genetic and environmental factors. Understanding the molecular mechanisms and signaling pathways involved in regeneration is essential for developing therapeutic strategies to enhance regeneration or repair damaged tissues. Advances in stem cell research, tissue engineering, and regenerative medicine hold promise for developing innovative treatments for organ injuries, degenerative diseases, and congenital defects, ultimately aiming to restore organ function and improve the quality of life for individuals with organ-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy